AL-HRAM PHARMA LTD

Company Registration Number:
07962062 (England and Wales)

Unaudited abridged accounts for the year ended 31 January 2026

Period of accounts

Start date: 01 February 2025

End date: 31 January 2026

AL-HRAM PHARMA LTD

Contents of the Financial Statements

for the Period Ended 31 January 2026

Balance sheet
Notes

AL-HRAM PHARMA LTD

Balance sheet

As at 31 January 2026


Notes
2026
2025


£
£
Called up share capital not paid: 9,404 11,755
Current assets
Stocks: 39,780 39,780
Debtors:   101,646 98,021
Cash at bank and in hand: 85,967 128,381
Total current assets: 227,393 266,182
Creditors: amounts falling due within one year:   (165,041) (428,509)
Net current assets (liabilities): 62,352 (162,327)
Total assets less current liabilities: 71,756 (150,572)
Creditors: amounts falling due after more than one year:   (91,908) (102,538)
Total net assets (liabilities): (20,152) (253,110)
Capital and reserves
Called up share capital: 300 300
Profit and loss account: (20,452) (253,410)
Shareholders funds: (20,152) (253,110)

The notes form part of these financial statements

AL-HRAM PHARMA LTD

Balance sheet statements

For the year ending 31 January 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 29 October 2026
and signed on behalf of the board by:

Name: Muhammad Obaid-Ur Rehman
Status: Director

The notes form part of these financial statements

AL-HRAM PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 January 2026

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

AL-HRAM PHARMA LTD

Notes to the Financial Statements

for the Period Ended 31 January 2026

2. Employees

2026 2025
Average number of employees during the period 5 5